does glp 1 increase sex drive Male sexual dysfunction associated with GLP-1 receptor agonists: a cross-sectional analysis of FAERS data A new study suggests GLP-1

Check out the links to the original studies at the end of this article

Peptides 185:171356

MEDI0382, a GLP1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: A randomised, controlled, doubleblind, ascending dose and phase 2a study

The mean percentage change in weight at week 72 was 15.0% (95% confidence interval [CI], 15.9 to 14.2) with 5-mg weekly doses of tirzepatide, 19.5% (95% CI, 20.4 to 18.5) with 10-mg doses, and 20.9% (95% CI, 21.8 to 19.9) with 15-mg doses

Individuals with a personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Type 2 (MEN 2) should not take a GLP-1 agonist